Obagi Medical Prices Below Range

Obagi Medical Products Inc., a Long Beach, Calif.-based pharma company focused on the aesthetic and therapeutic skin health markets, priced 5.35 million common shares at $11 per share ($13-$15 forecast), for an IPO take of approximately $58.9 million. It will trade on the Nasdaq under ticker symbol OMPI, whiled JPMorgan served as lead underwriter. Stonginton Partners was listed as the company's majority shareholder. www.obagi.com